Advancements in Magnetic Resonance Imaging-based Biomarkers for Muscular Dystrophy

Overview

Journal Muscle Nerve

Date 2019 Apr 27

PMID 31026060

Citations 11

Authors

Doris G Leung

Affiliations

Soon will be listed here.

Abstract

Recent years have seen steady progress in the identification of genetic muscle diseases as well as efforts to develop treatment for these diseases. Consequently, sensitive and objective new methods are required to identify and monitor muscle pathology. Magnetic resonance imaging offers multiple potential biomarkers of disease severity in the muscular dystrophies. This Review uses a pathology-based approach to examine the ways in which MRI and spectroscopy have been used to study muscular dystrophies. Methods that have been used to quantitate intramuscular fat, edema, fiber orientation, metabolism, fibrosis, and vascular perfusion are examined, and this Review describes how MRI can help diagnose these conditions and improve upon existing muscle biomarkers by detecting small increments of disease-related change. Important challenges in the implementation of imaging biomarkers, such as standardization of protocols and validating imaging measurements with respect to clinical outcomes, are also described.

Citing Articles

Quantitative magnetic resonance imaging parameters of lumbar paraspinal muscle impairment in myotonic dystrophy type 2 and their evolution with aging.

Kokosova V, Krkoska P, Vlazna D, Sladeckova M, Dostal M, Kerkovsky M Front Neurol. 2025; 16:1525952.

PMID: 40046670 PMC: 11879826. DOI: 10.3389/fneur.2025.1525952.

The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review.

Paik J, Christopher-Stine L, Boesen M, Carrino J, Eggleton S, Denis D Front Immunol. 2025; 16:1455867.

PMID: 39931069 PMC: 11808160. DOI: 10.3389/fimmu.2025.1455867.

Multi-parameter quantitative magnetic resonance imaging for early detecting skeletal muscle involvement and predicting functional decline in children with Becker muscular dystrophy.

Peng F, Xu H, Xu T, Xu K, Cai X, Tang D Pediatr Radiol. 2024; 55(1):136-150.

PMID: 39621041 DOI: 10.1007/s00247-024-06104-2.

Diagnostic and evaluative efficiency of Ga-FAPI-04 in skeletal muscle injury.

Wang Y, Li L, Wang H, Cheng J, Du C, Xu L EJNMMI Res. 2024; 14(1):88.

PMID: 39356393 PMC: 11447190. DOI: 10.1186/s13550-024-01147-w.

Iliopsoas fibrosis after revision of total hip arthroplasty revealed by Ga-FAPI PET/CT: a case report.

Wang Y, Sun Y, Song J, Zhang X, Li L, Shen Z Front Med (Lausanne). 2024; 11:1328630.

PMID: 38439900 PMC: 10909810. DOI: 10.3389/fmed.2024.1328630.

References

Petri H, Ahtarovski K, Vejlstrup N, Vissing J, Witting N, Kober L . Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014; 16:59. PMC: 4422258. DOI: 10.1186/s12968-014-0059-z. View

Sharma U, Atri S, Sharma M, Sarkar C, Jagannathan N . Biochemical characterization of muscle tissue of limb girdle muscular dystrophy: an 1H and 13C NMR study. NMR Biomed. 2003; 16(4):213-23. DOI: 10.1002/nbm.832. View

Goodwin D . Imaging of skeletal muscle. Rheum Dis Clin North Am. 2011; 37(2):245-51, vi-vii. DOI: 10.1016/j.rdc.2011.01.007. View

Mankodi A, Azzabou N, Bulea T, Reyngoudt H, Shimellis H, Ren Y . Skeletal muscle water T as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy. Neuromuscul Disord. 2017; 27(8):705-714. PMC: 5538585. DOI: 10.1016/j.nmd.2017.04.008. View

Kim H, Serai S, Lindquist D, Merrow A, Horn P, Kim D . Quantitative Skeletal Muscle MRI: Part 2, MR Spectroscopy and T2 Relaxation Time Mapping-Comparison Between Boys With Duchenne Muscular Dystrophy and Healthy Boys. AJR Am J Roentgenol. 2015; 205(2):W216-23. DOI: 10.2214/AJR.14.13755. View

Hooijmans M, Doorenweerd N, Baligand C, Verschuuren J, Ronen I, Niks E . Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up. PLoS One. 2017; 12(8):e0182086. PMC: 5538641. DOI: 10.1371/journal.pone.0182086. View

Yao L, Yip A, Shrader J, Mesdaghinia S, Volochayev R, Jansen A . Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies. Rheumatology (Oxford). 2015; 55(3):441-9. PMC: 4757924. DOI: 10.1093/rheumatology/kev344. View

Grimm A, Meyer H, Nickel M, Nittka M, Raithel E, Chaudry O . Evaluation of 2-point, 3-point, and 6-point Dixon magnetic resonance imaging with flexible echo timing for muscle fat quantification. Eur J Radiol. 2018; 103:57-64. DOI: 10.1016/j.ejrad.2018.04.011. View

Willcocks R, Arpan I, Forbes S, Lott D, Senesac C, Senesac E . Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression. Neuromuscul Disord. 2014; 24(5):393-401. PMC: 4277599. DOI: 10.1016/j.nmd.2013.12.012. View

10.

Shieh P . Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy. Neurotherapeutics. 2018; 15(4):840-848. PMC: 6277306. DOI: 10.1007/s13311-018-00687-z. View

11.

Ferguson M, Poliachik S, Budech C, Gove N, Carter G, Wang L . MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1. Muscle Nerve. 2017; 57(6):905-912. DOI: 10.1002/mus.26038. View

12.

Pichiecchio A, Alessandrino F, Bortolotto C, Cerica A, Rosti C, Raciti M . Muscle ultrasound elastography and MRI in preschool children with Duchenne muscular dystrophy. Neuromuscul Disord. 2018; 28(6):476-483. DOI: 10.1016/j.nmd.2018.02.007. View

13.

Borga M . MRI adipose tissue and muscle composition analysis-a review of automation techniques. Br J Radiol. 2018; 91(1089):20180252. PMC: 6223175. DOI: 10.1259/bjr.20180252. View

14.

Barbiroli B, McCully K, Iotti S, Lodi R, Zaniol P, Chance B . Further impairment of muscle phosphate kinetics by lengthening exercise in DMD/BMD carriers. An in vivo 31P-NMR spectroscopy study. J Neurol Sci. 1993; 119(1):65-73. DOI: 10.1016/0022-510x(93)90192-2. View

15.

Dahlqvist J, Vissing C, Thomsen C, Vissing J . Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy. Neurology. 2014; 83(13):1178-83. DOI: 10.1212/WNL.0000000000000828. View

16.

Ten Dam L, van der Kooi A, van Wattingen M, de Haan R, de Visser M . Reliability and accuracy of skeletal muscle imaging in limb-girdle muscular dystrophies. Neurology. 2012; 79(16):1716-23. DOI: 10.1212/WNL.0b013e31826e9b73. View

17.

Zhang M, Ma J, Shen Y, Chen Y . Optimal classification for the diagnosis of duchenne muscular dystrophy images using support vector machines. Int J Comput Assist Radiol Surg. 2015; 11(9):1755-63. DOI: 10.1007/s11548-015-1312-0. View

18.

Cai J, Xing F, Batra A, Liu F, Walter G, Vandenborne K . Texture Analysis for Muscular Dystrophy Classification in MRI with Improved Class Activation Mapping. Pattern Recognit. 2019; 86:368-375. PMC: 6521874. DOI: 10.1016/j.patcog.2018.08.012. View

19.

Nishizawa H, Genno H, Shiba N, Nakamura A . Periodic sound-based 6-minute walk test forpatients with Duchenne muscular dystrophy:a preliminary study. J Phys Ther Sci. 2015; 27(11):3473-9. PMC: 4681928. DOI: 10.1589/jpts.27.3473. View

20.

Kubinova K, Mann H, Vencovsky J . MRI scoring methods used in evaluation of muscle involvement in patients with idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2017; 29(6):623-631. DOI: 10.1097/BOR.0000000000000435. View